Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence of DNA-confirmed familial hypercholesterolaemia in young patients with myocardial infarction.

European journal of internal medicine - 1 Mar 2015

Wald David S, Bangash Fatima A, Bestwick Jonathan P

Abstract excerpt

PURPOSE: To report the prevalence of DNA-confirmed Familial Hypercholesterolaemia (FH) in young patients with acute myocardial infarction, the relative contribution of smoking and diabetes and to compare these rates with those in the general population. METHODS: A pilot clinical service was established to diagnose FH in young patients (≤50 years) with myocardial infarction at a London hospital. Over 23 months,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age of Onset
Share to Comorbidity
Share to Diabetes Mellitus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hydroxymethylglutaryl-CoA Reductase Inhibitors

Share to Hyperlipoproteinemia Type II

Share to London

Share to Myocardial Infarction

Share to Smoking

Source

Identifiers

PMID: 25682442
DOI: 10.1016/j.ejim.2015.01.014

Genes

LDLR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence of DNA-confirmed familial hypercholesterolaemia in young patients with myocardial infarction.PMID 25682442Read ↗

Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication.Semantic proximity Read ↗

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society.Semantic proximity Read ↗

Familial hypercholesterolaemia: a pressing issue for European health care.Semantic proximity Read ↗

What is the clinical utility of DNA testing in patients with familial hypercholesterolaemia?Semantic proximity Read ↗

Prevalence and management of familial hypercholesterolaemia in coronary patients: An analysis of EUROASPIRE IV, a study of the European Society of Cardiology.Semantic proximity Read ↗

Clinical and genetic diagnosis of familial hypercholesterolaemia in patients undergoing coronary angiography: the Ludwigshafen Risk and Cardiovascular Health Study.Semantic proximity Read ↗

Whole-exome sequencing in an extended family with myocardial infarction unmasks familial hypercholesterolemia.Semantic proximity Read ↗

Genetic testing for familial hypercholesterolaemia: practical and ethical issues.Semantic proximity Read ↗

Detection of familial hypercholesterolemia in patients from a general practice database.Semantic proximity Read ↗

Cardiovascular disease in patients with genotyped familial hypercholesterolemia in Norway during 1994-2009, a registry study.Semantic proximity Read ↗

Would raising the total cholesterol diagnostic cut-off from 7.5 mmol/L to 9.3 mmol/L improve detection rate of patients with monogenic familial hypercholesterolaemia?Semantic proximity Read ↗

Impact of clinical signs and genetic diagnosis of familial hypercholesterolaemia on the prevalence of coronary artery disease in patients with severe hypercholesterolaemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.